Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2020-05-12 | 2020-05-01 |
| Drug Identification Number | 00781878 | 00781878 |
| Brand name | VITAMIN K1 INJ 1MG/0.5ML USP | VITAMIN K1 INJ 1MG/0.5ML USP |
| Common or Proper name | VITAMIN K1 INJ 2MG/0.5 ML | VITAMIN K1 INJ 2MG/0.5 ML |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | VITAMIN K1 | VITAMIN K1 |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | EMULSION | EMULSION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10MG/ML | 10MG/ML |
| ATC code | B02BA | B02BA |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2020-05-01 | 2020-05-01 |
| Estimated end date | 2020-05-08 | 2020-05-08 |
| Actual end date | 2020-05-07 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Release delay at manufacturing site. Product had been placed on allocation at 50% of historical usage. Alternative product 9110 VITAMIN K1 INJ 10MG/ML remains available and is on protective allocation at 125% of historical usage. | Release delay at manufacturing site. Product had been placed on allocation at 50% of historical usage. Alternative product 9110 VITAMIN K1 INJ 10MG/ML remains available and is on protective allocation at 125% of historical usage. |
| Health Canada comments |